Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mangan

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2025
Glyceraldehyde-3-phosphate dehydrogenase homologs as bifunctional gatekeepers of metabolic segregation in <i><i>Pseudomonas</i> putida</i>Nanqing Zhou, Caroll M Mendonca, Austin L Carroll, et al.
Emerging Infectious Diseases|February 19, 2016
Factors Associated with Loss to Follow-up during Treatment for Multidrug-Resistant Tuberculosis, the Philippines, 2012-2014Thelma E Tupasi, Anna Marie Celina G Garfin, Ekaterina V Kurbatova, et al.
American Journal of Public Health|September 17, 2020
Cost of Tuberculosis Therapy Directly Observed on Video for Health Departments and Patients in New York City; San Francisco, California; and Rhode Island (2017-2018)Garrett R Beeler Asay, Chee Kin Lam, Brock Stewart, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 12, 2016
Multidrug-resistant tuberculosis patients lost to follow-up: self-reported readiness to restart treatmentJ M Mangan, T E Tupasi, A M C G Garfin, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 4, 2017
Multidrug-resistant tuberculosis patients' views of interventions to reduce treatment loss to follow-upT Tupasi, A M C G Garfin, J M Mangan, et al.
Nature Communications|June 26, 2024
Deconstructing synthetic biology across scales: a conceptual approach for training synthetic biologistsAshty S Karim, Dylan M Brown, Chloé M Archuleta, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2024
Developing, characterizing and modeling CRISPR-based point-of-use pathogen diagnosticsJaeyoung K Jung, Kathleen S Dreyer, Kate E Dray, et al.
ACS Synthetic Biology|December 13, 2024
Developing, Characterizing, and Modeling CRISPR-Based Point-of-Use Pathogen DiagnosticsJaeyoung K Jung, Kathleen S Dreyer, Kate E Dray, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 25, 2024
Facilitators and barriers to adolescent participation in a TB clinical trialJ M Mangan, K N C Hedges, M M Salerno, et al.
The Review of Scientific Instruments|October 2, 2024
Erratum: "Radiation, optical, power flow, and electrical diagnostics at the Z facility: Layout and techniques utilized to operate in the harsh environment" [Rev. Sci. Instrum. 94, 031102 (2023)]T J Webb, D E Bliss, G A Chandler, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2025
Glyceraldehyde-3-phosphate dehydrogenase homologs as bifunctional gatekeepers of metabolic segregation in <i><i>Pseudomonas</i> putida</i>Nanqing Zhou, Caroll M Mendonca, Austin L Carroll, et al.
Emerging Infectious Diseases|February 19, 2016
Factors Associated with Loss to Follow-up during Treatment for Multidrug-Resistant Tuberculosis, the Philippines, 2012-2014Thelma E Tupasi, Anna Marie Celina G Garfin, Ekaterina V Kurbatova, et al.
American Journal of Public Health|September 17, 2020
Cost of Tuberculosis Therapy Directly Observed on Video for Health Departments and Patients in New York City; San Francisco, California; and Rhode Island (2017-2018)Garrett R Beeler Asay, Chee Kin Lam, Brock Stewart, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 12, 2016
Multidrug-resistant tuberculosis patients lost to follow-up: self-reported readiness to restart treatmentJ M Mangan, T E Tupasi, A M C G Garfin, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 4, 2017
Multidrug-resistant tuberculosis patients' views of interventions to reduce treatment loss to follow-upT Tupasi, A M C G Garfin, J M Mangan, et al.
Nature Communications|June 26, 2024
Deconstructing synthetic biology across scales: a conceptual approach for training synthetic biologistsAshty S Karim, Dylan M Brown, Chloé M Archuleta, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2024
Developing, characterizing and modeling CRISPR-based point-of-use pathogen diagnosticsJaeyoung K Jung, Kathleen S Dreyer, Kate E Dray, et al.
ACS Synthetic Biology|December 13, 2024
Developing, Characterizing, and Modeling CRISPR-Based Point-of-Use Pathogen DiagnosticsJaeyoung K Jung, Kathleen S Dreyer, Kate E Dray, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 25, 2024
Facilitators and barriers to adolescent participation in a TB clinical trialJ M Mangan, K N C Hedges, M M Salerno, et al.
The Review of Scientific Instruments|October 2, 2024
Erratum: "Radiation, optical, power flow, and electrical diagnostics at the Z facility: Layout and techniques utilized to operate in the harsh environment" [Rev. Sci. Instrum. 94, 031102 (2023)]T J Webb, D E Bliss, G A Chandler, et al.
Pageof 10